Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. The company offers pre-clinical research, clinical research, and other consulting services. It also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.
Research context
Guangzhou Boji Medical & Biotechnological Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Guangzhou Boji Medical & Biotechnological Co., Ltd is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.
From a valuation standpoint, the stock is 3.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.0.
Guangzhou Boji Medical & Biotechnological Co., Ltd's total revenue rose by 37.2% to $67M since the same quarter in the previous year.
Its net income has increased by 185.6% to $8M since the same quarter in the previous year.
Finally, its free cash flow grew by 101.4% to $176K since the same quarter in the previous year.
Based on the above factors, Guangzhou Boji Medical & Biotechnological Co., Ltd gets an overall score of 4/5.